Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The orexin1 receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats
Bianca Jupp, Bedrija Krivdic, Elena Krstew, et al.
Brain Research (2011) Vol. 1391, pp. 54-59
Closed Access | Times Cited: 136

Showing 26-50 of 136 citing articles:

Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner
David E. Moorman, Morgan H. James, Elisabeth A. Kilroy, et al.
European Journal of Neuroscience (2016) Vol. 43, Iss. 5, pp. 710-720
Open Access | Times Cited: 67
The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice
Marcelo F. Lopez, David E. Moorman, Gary Aston‐Jones, et al.
Brain Research (2016) Vol. 1636, pp. 74-80
Open Access | Times Cited: 66
Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats
Robyn M. Brown, Andrezza K. Kim, Shaun Yon‐Seng Khoo, et al.
Addiction Biology (2015) Vol. 21, Iss. 3, pp. 603-612
Open Access | Times Cited: 64
Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin‐1 receptor antagonist in rats
Morgan H. James, Hannah E. Bowrey, Colin M. Stopper, et al.
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2602-2612
Open Access | Times Cited: 64
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases
Yu Sun, Ryan K. Tisdale, Thomas S. Kilduff
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 22-37
Open Access | Times Cited: 42
Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33
Binge eating, overeating and food addiction: Approaches for examining food overconsumption in laboratory rodents
Robyn M. Brown, Morgan H. James
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 123, pp. 110717-110717
Open Access | Times Cited: 19
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Optogenetic recruitment of hypothalamic corticotrophin-releasing-hormone (CRH) neurons reduces motivational drive
Caitlin S. Mitchell, Erin J. Campbell, Simon D. Fisher, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration
Subhashini Srinivasan, Jeffrey A. Simms, Carsten K. Nielsen, et al.
PLoS ONE (2012) Vol. 7, Iss. 9, pp. e44726-e44726
Open Access | Times Cited: 69
N‐(2‐methyl‐6‐benzoxazolyl)‐N′‐1,5‐naphthyridin‐4‐yl urea (SB334867), a hypocretin receptor‐1 antagonist, preferentially prevents ethanol seeking: comparison with natural reward seeking
Rémi Martin‐Fardon, Friedbert Weiss
Addiction Biology (2012) Vol. 19, Iss. 2, pp. 233-236
Open Access | Times Cited: 62
Binge‐Like Consumption of Ethanol and Other Salient Reinforcers is Blocked by Orexin‐1 Receptor Inhibition and Leads to a Reduction of Hypothalamic Orexin Immunoreactivity
Jeffrey J. Olney, Montserrat Navarro, Todd E. Thiele
Alcoholism Clinical and Experimental Research (2015) Vol. 39, Iss. 1, pp. 21-29
Open Access | Times Cited: 58
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Orexin receptor antagonists as therapeutic agents for insomnia
Ana Clementina Equihua-Benítez, Alberto K. De la Herrán-Arita, René Drucker-Colı́n
Frontiers in Pharmacology (2013) Vol. 4
Open Access | Times Cited: 57
Orexin/Hypocretin System: Role in Food and Drug Overconsumption
Jessica R. Barson, Sarah F. Leibowitz
International review of neurobiology (2017), pp. 199-237
Open Access | Times Cited: 56
Differential role of hypothalamic orexin/hypocretin neurons in reward seeking motivated by cocaine versus palatable food
Rémi Martin‐Fardon, Gabrielle Cauvi, Tony M. Kerr, et al.
Addiction Biology (2016) Vol. 23, Iss. 1, pp. 6-15
Open Access | Times Cited: 55
Hypothalamic neuropeptide signaling in alcohol addiction
Jessica R. Barson, Sarah F. Leibowitz
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 65, pp. 321-329
Open Access | Times Cited: 54
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Drug addiction: An affective-cognitive disorder in need of a cure
Liana Fattore, Marco Diana
Neuroscience & Biobehavioral Reviews (2016) Vol. 65, pp. 341-361
Closed Access | Times Cited: 49
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report
Erin J. Campbell, Yvonne Bonomo, Lisa Collins, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 5
Effects of daridorexant on rest/wake activity patterns and drinking in adult rats exposed to chronic ethanol vapor in adolescence
Leslie R. Amodeo, Derek N. Wills, Jason Benedict, et al.
Alcohol (2025)
Open Access
Genetic associations between orexin genes and phenotypes related to behavioral regulation in humans, including substance use
Fazil Alıev, David De Sa Nogueira, Gary Aston‐Jones, et al.
Molecular Psychiatry (2025)
Open Access

Scroll to top